Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial
暂无分享,去创建一个
S. Senan | T. D. de Gruijl | P. M. van de Ven | J. Garcia-Vallejo | D. Oprea-Lager | M. Fransen | J. Veltman | I. Bahce | C. Dickhoff | F. Schneiders | L. Meijboom | I. Bartelink | T. Radonic | J. Daniels | S. Hashemi | David J. Heineman | I. Bahce